OPEN Foundation

Search
Close this search box.

PSYCHEDELIC MICRODOSING:
A PANEL DISCUSSION ON SCIENCE AND STORIES

🗣 Amanda Feilding (Founder of Beckley Foundation), Rotem Petranker (Director of Canadian Centre for Psychedelic Science), Balazs Szigeti (Imperial College’s Center for Psychedelic Research), and Eline Haijen (Maastricht University).

⏰ Wednesday 10 May, 8PM CEST

📍 Online (OPEN Community Platform)

We are delighted to present Amanda Feilding, Rotem Petranker, Balazs Szigeti and Eline Haijen in this panel discussion on the science and stories behind psychedelic microdosing. They provide a comprehensive overview of the topic as well as their insights into the latest research on psychedelic microdosing.

Microdosing has gained popularity in recent years. It involves taking small, controlled doses of psychedelic substances to enhance creativity, productivity, and emotional well-being. However, there is still much to be learned about the long-term effects and risks associated with microdosing.

This event is an excellent opportunity for anyone interested in learning more about microdosing.

ABOUT THE SPEAKERS

Microdosing-Panel-OPEN-Foundation-Online-Event-Page-May-2023-Square

Amanda Feilding is founder and executive director of the Beckley Foundation. She has been called the ‘hidden hand’ behind the Renaissance of Psychedelic Science, and her contribution to the advancement of psychedelic research and global drug policy has been pivotal and widely acknowledged. 

Rotem Petranker is co-founder and director of the Psychedelic Science Research Program at the University of Toronto, Canada. His main research interests are sustained attention, emotional regulation, and creativity, all of which may be affected by psychedelics. 

Balazs Szigeti is a postdoctoral researcher at Imperial College’s Center for Psychedelic Research. He invented ‘self-blinding’, using this methodology Balázs lead the ‘self-blinding microdose trial, the largest placebo-controlled study on psychedelic microdosing to-date.

Eline Haijen is a PhD candidate in the Psychopharmacology in Maastricht research group at the department of Neuropsychology and Psychopharmacology at Maastricht University.

16 July - NDE's and Psychedelic Experiences: Commonalities & Insights

X